Also noted were more EMBx supported AMR (4.8% vs 0.9%) and treated AMR (4.8% vs 2.7%), however these did not reach statistical significance.
← all excerpts
A modern heart transplant rejection surveillance protocol utilizing cell-free DNA: A single-center experience.
1
—
—